Dr. Hanadie YousefFounder

United States - San Francisco Bay Area

I build and govern AI-driven biotechnology companies as a scientist, entrepreneur, and executive.

I founded Juvena Therapeutics in 2017 based on over a decade of my research discoveries. Serving as CEO, CFO, and Board Chair through 2025, I scaled the company from a platform concept to first-in-human clinical development. During my tenure, I led scientific strategy, capital formation, and global partnerships—raising >$105M in venture and non-dilutive capital and securing a strategic discovery collaboration with Eli Lilly.

My work focuses on platform-first innovation that integrates biology, multi-omics, and AI to create durable pipelines rather than single assets. I oversee translational strategy from discovery through clinical execution, managing complex stakeholder environments to guide organizations through critical inflection points—from financing to leadership transitions.

As a board member, I bring a unique blend of founder, scientist, and engineer perspectives, with strong fluency in capital strategy, risk management, and long-term value creation. I combine data-driven rigor with creative problem-solving and am particularly interested in board roles across biotech, AI-enabled healthcare, and healthspan-focused companies.

Beyond the lab and boardroom, I am passionate about education as a human right. I serve as a dedicated volunteer and Board Director for the AMY Fund, which I co-founded with my sister, Bassema Yousef, in 2021 to honor our father’s legacy and empower refugees through higher education.

I was named a World Economic Forum Technology Pioneer and a Mayfield | Divot Industry Leader in AI. I hold a B.S. summa cum laude from Carnegie Mellon, a PhD from UC Berkeley (NSF Fellow), and completed 5 years of postdoctoral training at Stanford School of Medicine (NIH Fellow/SPARK Scholar). My career in discovery began early, starting research at Regeneron at age 15.